SCHEMBL7010265

SCHEMBL7010265

Cc1cccc(C)c1CNc1cccn2c(C(O)O)cnc12

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 14/20 0.47
CYP2C9 P11712 13/20 0.47
CYP2D6 P10635 9/20 0.47
CYP2C19 P33261 8/20 0.47
CYP1A2 P05177 8/20 0.47
HDAC8 Q9BY41 1/20 0.44
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
TYK2 P29597 1/20 0.38
JAK3 P52333 1/20 0.38
TTK P33981 1/20 0.36
CD38 P28907 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7145796 0.80 CYP3A4 (0.43) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL6351638 0.72 CYP3A4 (0.59) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL6351492 0.72 CYP3A4 (0.81) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL7492158 0.72 CYP3A4 (0.61) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL6350758 0.71 CYP3A4 (0.64) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL7012480 0.71 CYP3A4 (0.51) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL6354270 0.71 CYP3A4 (0.60) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL7009385 0.71 CYP3A4 (0.56) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL6354794 0.70 CYP3A4 (0.62) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2
SCHEMBL7101013 0.70 CYP3A4 (0.62) CYP3A4CYP2C9CYP2D6CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6613775-B1 8-(2,6-dimethylbenzylamino)-2-hydroxymethyl-3-methylimidazo(1, 2-a)pyridine used as antisecretory agents for prophylaxis of gastrointestinal disorders such as ulcers ASTRAZENECA AB (SE) 2003-09-02 US claimed
EP-1105390-B1 Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases ASTRAZENECA AB (SE) 2003-06-04 EP claimed
EP-1105390-A2 NEW COMPOUNDS AstraZeneca AB (SE) 2001-06-13 EP claimed
WO-2000010999-A2 NEW COMPOUNDS ASTRAZENECA AB (SE) 2000-03-02 WO claimed
US-6613775-B1 8-(2,6-dimethylbenzylamino)-2-hydroxymethyl-3-methylimidazo(1, 2-a)pyridine used as antisecretory agents for prophylaxis of gastrointestinal disorders such as ulcers ASTRAZENECA AB (SE) 2003-09-02 US disclosed
EP-1105390-B1 Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases ASTRAZENECA AB (SE) 2003-06-04 EP disclosed